Completion of a reserved share capital increase of Median Technologies to FURUI of €19.6 Million at a €13 per share price

Sophia Antipolis, France

Median Technologies, the Imaging Phenomics™ Company announced in a press release dated November 16th, 2016  that it had entered into an investment agreement with Furui Medical Science Company Luxembourg, a wholly owned subsidiary of Inner Mongolia Furui Medical Science Co., Ltd. (FURUI), according to which Median Technologies will issue and Furui Medical Science Company Luxembourg will subscribe 1,507,692 new ordinary shares of the company at a price of €13.00 per share representing a total amount of €19,599,996 through a reserved share capital increase.

Today, Median Technologies announces the completion of this share capital increase.

This share capital increase will allow Median Technologies mainly to develop business opportunities for China for the company’s products and also for general working capital and other general corporate purposes of the company.

After completion of this transaction, the share capital of Median Technologies is 579,601.30 euros and the total number of shares is 11,592,026 representing 11,575,006 voting rights.

The newly issued shares are assimilated to the existing ordinary shares of the company and listed on Alternext on the same listing line of the existing shares under ISIN Code: FR0011049824. After completion of the transaction, Furui Medical Science Company Luxembourg holds 13.01% of the share capital and 13.03% of the voting rights of Median Technologies.

The original version of this press release is the French version. This version is a translation and should in no way be considered official. The original French version shall prevail over this translation in English. The translation must always be construed according to the original version in French.

Download 20161219_PR_FURUI_post_OEGM_EN.pdf